Manufacturing

Articles

Gerresheimer and Nelson Labs will work together to conduct extractables and leachables testing on upcoming primary packaging solutions.

Gerresheimer and Nelson Labs NV Announce E&L Partnership

Recipharm’s new high speed filling line, designed for pre-filled syringes and cartridges, is expected to be operational by May 2023.

Recipharm to Add High-Speed Filling Line to Wasserburg Facility

Lubrizol has launched Apisolex technology to improve solubility and simplify the manufacturing of parenteral drug products.

Lubrizol Launches Apisolex Technology 

Takeda’s TAKHZYRO prefilled syringe is now available for patients with hereditary angioedema aged 12 years and older in the United States.

Takeda’s TAKHZYRO Prefilled Syringe Now Available for Patients with Hereditary Angioedema

Eli Lilly and Company is investing $1 billion to establish a new manufacturing stie in Concord, N.C., to manufacture parenteral products and devices.

Lilly to Invest $1 Billion to Build New Parenteral Manufacturing Facility in North Carolina

Meg Rivers is the former senior editor for 

Build into the chemistry, manufacturing, and control strategy the ability to pivot and be flexible should the course change.

A Customized Regulatory Approach to CMCs

Baxter will invest $100 million in new lyophilization equipment and an additional aseptic syringe filling line at its Halle/Westfalen (Germany) location.

Baxter Invests in its German Sterile Fill/Finish Manufacturing Facility

Jessica Baseggio is research laboratory analysts at SG Lab Analytics, Stevanato Group.

Chiara Callegari is research laboratory analysts at SG Lab Analytics, Stevanato Group.

Enrico Barichello is SG Alba Platform product manager, Stevanato Group, 

A coating technology for a staked needle prefillable syringe reduces the potential risks associated with silicone oil as a lubricant.

Considering a Coating Technology as an Alternative to Silicone Oil

In this collaboration, Takeda will utilize Poseida's biodegradable DNA and RNA nanoparticle delivery technology and other proprietary genetic engineering platforms for the research and development of gene therapies.

Poseida Therapeutics and Takeda Partner to Develop Non-Viral In-Vivo Gene Therapy Programs

Lilly’s insulin, lyumjev, receives FDA approval for an expanded label.

Manufacturing, Parenterals and Injectables